Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002.

S. Lippman,W. Hong
IF: 13.801
2002-02-01
Clinical Cancer Research
Abstract:Chemoprevention only recently matured into a standard modality for controlling epithelial carcinogenesis. This maturity resulted from the landmark United States FDA[3][1] approvals of tamoxifen for reducing breast cancer risk in three settings [(1)][2] and from FDA approvals of several agents for
What problem does this paper attempt to address?